Rinvoq Cost in 2026: Prices & How to Save

If your pharmacy quoted somewhere north of $7,000 for a month of Rinvoq, that number is real — and it's not a mistake or a first-fill fluke. A single 30-day bottle of these little once-a-day tablets carries a list price higher than a used car payment stretched across the whole year.

That's a hard thing to absorb when you've just been handed a prescription for a drug you may take indefinitely. Here's what Rinvoq actually costs in 2026, why the price sits where it does, and the cash-pay routes that can bring a month closer to $1,800 than $8,000.

How much does Rinvoq cost in 2026?

Rinvoq (generic name upadacitinib) has a wholesale acquisition cost — the manufacturer's list price — of about $7,090.41 for a 30-day supply as of January 2026. That's the anchor number behind your copay, your coinsurance, and the cash price if you don't have coverage.

Rinvoq is an oral JAK inhibitor, taken as one extended-release tablet a day. It treats a long list of inflammatory conditions: rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis (eczema), ulcerative colitis, and Crohn's disease, among others. Because it's a once-daily pill rather than an injection or infusion, the cost is easy to think about by the month — one bottle, one month.

The catch is that "one month" can mean very different dollar figures depending on your dose.

Rinvoq cost by dose and strength

Rinvoq comes in 15 mg, 30 mg, and 45 mg strengths. Higher strengths cost more, and some conditions require the stronger doses. Rheumatoid arthritis is usually the 15 mg once daily. Ulcerative colitis and Crohn's often start with a 45 mg induction course before stepping down. Eczema may use 15 mg or 30 mg.

Typical US cash prices in 2026:

Strength	Quantity	Approximate US cash price
15 mg	30 tablets	~$6,900 – $7,825
30 mg	30 tablets	~$8,900
45 mg	28 tablets	~$15,450

So the same drug can run anywhere from roughly $7,000 to over $15,000 a month depending on which strength you're prescribed. When you read a single headline price for Rinvoq, check which dose it's quoting — a 15 mg figure won't match a 45 mg reality.

Rinvoq cost per month and per year

Because it's a daily pill dispensed 30 at a time, Rinvoq's monthly cost is essentially the price of one bottle. At the list price, that's about $7,090 a month, which works out to roughly $85,000 a year for the 15 mg dose. On the 45 mg dose, the annual figure climbs well past $150,000.

Those are the sticker numbers. What you actually pay depends on coverage — and that's where the range gets wide.

Why is Rinvoq so expensive?

Two things keep the price high. First, developing a targeted drug like this takes years of research and clinical trials, and that cost gets baked into the launch price. Second, and more importantly right now, Rinvoq has no competition.

Upadacitinib is still under patent, and there's no generic or biosimilar version on the US market. When a drug loses exclusivity, generic manufacturers move in and prices usually fall — that's what's slowly happening to older biologics like Humira, which now has several lower-cost biosimilars. Rinvoq isn't there yet, so the brand sets the price with nothing pulling it down.

Rinvoq cost without insurance

Paying cash at a US retail pharmacy, you're generally looking at something close to the list price. Reported 2026 figures for a 30-day supply of the 15 mg tablets land between about $6,900 and $8,800, depending on the pharmacy. One widely cited retail average puts 30 tablets around $8,464.

For a lot of people, that's simply not payable month after month — which sends them looking for another way to buy the exact same medication.

Rinvoq cost with insurance and Medicare

If you have commercial insurance that covers Rinvoq, your monthly cost depends on your plan's specialty tier, your deductible, and where you are in the plan year. Many plans require prior authorization, and some require step therapy — trying a cheaper drug first — before they'll approve it.

Medicare Part D can cover Rinvoq, but not everyone's plan does, and it never falls under Part A or Part B. One meaningful change: under current rules, Part D enrollees have an annual out-of-pocket cap of $2,000 on covered drugs. That cap can make a huge difference for a drug priced like Rinvoq — but it only helps if your specific plan covers it, so check your formulary before assuming.

How to save on Rinvoq

There's no generic to switch to, so the savings levers here are practical rather than magic.

Compare cash-pay pricing. This is the biggest one for Rinvoq. Because the US cash price is so high, a licensed international pharmacy can represent thousands of dollars in monthly savings. Through CanAmerica Plus, Rinvoq 15 mg runs around $1,800 for a 30-day supply versus roughly $6,900 or more at US retail — worth pricing out directly before you assume the pharmacy counter number is fixed.

Ask whether a different drug fits. Rinvoq isn't the only option for most of its approved conditions, and a different medication — or an older one with a biosimilar — may cost far less. This is strictly a conversation for your prescriber, since these drugs work differently and aren't interchangeable. More on the alternatives below.

Confirm your dose. Since a 45 mg month costs roughly double a 15 mg month, making sure you're on the lowest effective dose your doctor recommends is both a clinical and a financial question.

Recheck pricing before each refill. Specialty drug prices and pharmacy contracts change. The number you were quoted last quarter may not be today's, so verify before every order.

How Rinvoq compares to other options

If cost is a barrier, it helps to know the neighborhood. These are prescriber decisions, but here's how Rinvoq sits next to the drugs it's most often weighed against:

Medication	Class	Form	Notes
Rinvoq (upadacitinib)	JAK inhibitor	Daily tablet	No generic yet
Xeljanz (tofacitinib)	JAK inhibitor	Tablet	Same class, no generic yet
Humira (adalimumab)	TNF inhibitor	Injection	Multiple biosimilars, lower cash prices
Skyrizi (risankizumab)	IL-23 inhibitor	Injection	For psoriasis, PsA, Crohn's
Dupixent (dupilumab)	IL-4/13 inhibitor	Injection	Common for eczema

Humira stands out here because its biosimilars have pushed cash prices down in a way that hasn't happened for Rinvoq or Xeljanz. That doesn't make it the right choice for you — the mechanism, your diagnosis, how you've responded to past treatments, and side-effect risks all matter more than price. But if affordability is threatening your ability to stay on treatment at all, it's a fair thing to raise with your doctor.

A note on Rinvoq's safety profile

Cost isn't the only reason to talk this through carefully. Rinvoq carries an FDA boxed warning — the agency's strongest — covering the risk of serious infections, blood clots, certain cancers including lymphoma, and major cardiovascular events like heart attack and stroke. The risk is higher in people over 50 with a heart-disease risk factor, and in current or former smokers.

None of that means the drug is wrong for you; for many people the benefit clearly outweighs the risk. It does mean the decision to start, continue, or switch Rinvoq belongs with your prescriber, not a price comparison. For related reading, see our guide to Humira side effects.

The bottom line

Rinvoq is expensive by any measure — roughly $7,090 a month at list price, more for the higher strengths, with no generic yet to soften it. What you can control is where you buy it. Cash-pay pricing through a licensed international pharmacy such as CanAmerica Plus can bring a month of the 15 mg dose to around $1,800, and confirming your dose and coverage can shave more. Start by comparing real cash prices, and keep the medical decision where it belongs — with your doctor.

Frequently asked questions

How much does Rinvoq cost per month?

At the US list price, about $7,090 for a 30-day supply of the standard 15 mg dose. Cash prices at US pharmacies typically run $6,900 to $8,800 a month, while the 45 mg strength can exceed $15,000. Cash-pay pricing through a licensed international pharmacy can bring the 15 mg dose to roughly $1,800 a month.

Why is Rinvoq so expensive?

It's a patent-protected brand-name drug with no generic or biosimilar competition in the US. Development costs and market exclusivity keep the price high, and until a generic upadacitinib launches, there's nothing cheaper undercutting it.

Is there a generic for Rinvoq?

Not yet. As of 2026, there is no generic or biosimilar version of upadacitinib available in the US. Brand-name Rinvoq is the only option, though cash-pay sourcing through a licensed international pharmacy can still cut what you pay substantially.

How much does Rinvoq cost without insurance?

Roughly $6,900 to $8,800 for a 30-day supply of the 15 mg tablets at US retail, and more for higher strengths. A licensed international pharmacy through a cash-pay network like CanAmerica Plus prices the 15 mg dose around $1,800 for the same 30-day supply.

Does Medicare cover Rinvoq?

Sometimes. Rinvoq can be covered under Medicare Part D or a Medicare Advantage plan that includes drug coverage, but never under Part A or Part B, and not every Part D plan lists it. Part D's $2,000 annual out-of-pocket cap can help significantly if your plan covers the drug, so check your formulary.

---

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Pricing information is current as of the publication date but may change. Verify pricing directly before making purchasing decisions.